A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease

Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease: Insights From a Meta-analysis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01036048

Enrollment

5806

Registered

2009-12-21

Start date

2009-05-31

Completion date

2009-12-31

Last updated

2009-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Saphenous Vein Graft Disease

Keywords

saphenous vein graft, stent

Brief summary

A meta-analysis to compare outcomes of drug eluting stents (DES) versus bare metal stent (BMS) in saphenous vein graft (SVG) disease.

Detailed description

To compare outcomes (death, myocardial infarction, target vessel revascularization) of drug eluting stent versus bare metal stent in saphenous vein graft disease.

Interventions

DEVICEdrug eluting stent

pts with cabg disease treated with drug eluting stent

DEVICEbare metal stent

pts with cabg disease treated with bare metal stent

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* CABG disease * randomized studies * not randomized studies

Exclusion criteria

* studies reporting composite and not single endpoints, duplicate reporting

Design outcomes

Primary

Measure	Time frame
death	years depending from studies retrieved

Secondary

Measure	Time frame
myocardial infarction	years depending from study retrieved
target vessel revascularization	years depending from study retrieved

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026